Results 131 to 140 of about 2,137 (167)
Emergent metabolic interactions in resistance toClostridioides difficileinvasion
Ambat A +9 more
europepmc +1 more source
Clostridium difficile Infection and Fecal Bacteriotherapy
Gastroenterology Nursing, 2013 Clostridium difficile, also called "C. diff," is a gram-positive bacillus associated with nosocomial infections involving diarrhea, most often seen in developing countries. The severity of C. diff-associated diarrhea varies tremendously from mild and self-limiting to fulminant and life-threatening. C.
Indya, Mitchell +2 more
+6 more sources
Fecal Bacteriotherapy, Fecal Transplant, and the Microbiome
Journal of Clinical Gastroenterology, 2010 In this issue, there are 3 papers published that involve the fecal microbiome. One is an important physiologic study and 2 are a further elaboration of treatment using fecal bacteriotherapy, now often referred to as fecal transplantation.In the paper from Australia, Grehan et al1 describe the ...
Martin H. Floch
openaire +3 more sources
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Anaerobe, 2009 Clostridium difficile infection (CDI) has emerged as a major complication associated with the use of systemic antimicrobial agents. Broad-spectrum antimicrobial agents disrupt the ecological bacterial balance in the colon and create an opportunity for C.
Johan Bakken
openaire +3 more sources
Bacteriotherapy Using Fecal Flora
Journal of Clinical Gastroenterology, 2004 The intestinal flora may play a key role in the pathogenesis of certain gastrointestinal (GI) diseases. Components of bowel flora such as Lactobacillus acidophilus and Bifidobacterium bifidus have long been used empirically as therapeutic agents for GI disorders. More complex combinations of probiotics for therapeutic bacteriotherapy have also recently
Thomas J, Borody +5 more
openaire +3 more sources
Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?
Current Infectious Disease Reports, 2013 In recent years, effective management of recurrent Clostridium difficile infection (CDI) has emerged as an important issue for those clinicians who treat patients with CDI. In addition to antibiotic-based therapies, including alternating use, chaser, and tapering protocols, interest has increased in the potential utility of a variety of nonantibiotic ...
Nuntra, Suwantarat, David A, Bobak
openaire +3 more sources
Fecal Bacteriotherapy for Clostridium difficile Infections — Its Time Has Come
Clinical Microbiology Newsletter, 2013 Abstract Clostridium difficile treatment failures and recurrences occur at rates of 22.3% and 22.1%, respectively. For patients who have refractory/recurrent disease, there are limited treatment options. The use of a fecal suspension from a healthy donor instilled via a nasogastric tube, during colonoscopy, or by enema in a patient with recurrent or
Avery, Lisa M., Hasan, Muhammad
openaire +3 more sources
Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Journal of Clinical Gastroenterology, 2003 Although the etiology of idiopathic ulcerative colitis (UC) remains poorly understood, the intestinal flora is suspected to play an important role. Specific, consistent abnormalities in flora composition peculiar to UC have not yet been described, however Clostridium difficile colitis has been cured by the infusion of human fecal flora into the colon ...
Thomas J, Borody +4 more
openaire +3 more sources
Fecal bacteriotherapy or probiotics for the treatment of intestinal diseases?
American Journal of Gastroenterology, 2001 Giuseppe Famularo +2 more
+5 more sources